|
EDUCATION
AND TRAINING
| Undergraduate |
University
of Notre Dame |
|
Medical
degree
|
Ohio
State University
Columbus, Ohio
|
|
Internship
|
Rush-Presbyterian
St. Luke's, Chicago
|
|
Residency
|
Ohio State University
|
| Fellowship |
The
University of Chicago,
Illinois |
BOARD CERTIFICATION
Radiation Oncology (American
Board of Radiology)
OTHER
American Cancer Society Fellow,
1992-3
Attending physician, University
of Chicago, 1993-1998
AREAS OF SPECIALTY
- Prostate cancer
- Head & neck cancer
- Sarcomas
- Stereotactic radiosurgery
- Stereotactic radiotherapy
- Gynecologic malignancies
Dr. Sweeney is the Medical Director of Radiation Oncology at the Illinois Gamma Knife Center in Elk Grove Village, IL. He primarily practices at the Illinois Gamma Knife Center and Good Samaritan Hospital in Downers Grove, IL. He is board-certified in Radiation Oncology. After completing residency at Ohio State University and an American Cancer Society Fellowship at the University of Chicago, he was an Assistant Professor for the Department of Radiation and Cellular Oncology in the University of Chicago Center for Radiation Therapy for 5 years. He has been in private practice with Radiation Oncology Consultants since 1998.
Dr. Sweeney has expertise in brain tumors, sarcomas, and prostate cancers. He is experienced in the use of conformal 3-D therapy, intensity modulated radiation therapy (IMRT), stereotactic radiosurgery using Gamma Knife, and high dose rate brachytherapy. He is also knowledgeable in breast, lung, head & neck, gastrointestinal, and gynecologic malignancies. Dr. Sweeney is an active member in numerous professional organizations. He has written numerous papers, and given local and national lectures on various cancer topics.
Dr. Sweeney spends his leisure time with his wife and four children. He is an avid reader and Notre Dame sports fan.
When asked why he chose Radiation Oncology he states, "I find a great deal of fulfillment in the care of oncology patients and their families. I enjoy the ability that we now have to integrate cutting-edge technologies into the treatment of tumors. This has clearly helped our patients live longer and with a better quality of life."
|
